Urinary glucaric acid excretion in rheumatoid arthritis: Influence of disease activity and disease modifying drugs

Annals of the Rheumatic Diseases

Volumn 55, Issue 7, 1996, Pages 478-481

  Addyman, R ^a   Beyeler, C ^b   Astbury, C ^a   Bird, H A ^a  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; PENICILLAMINE; SACCHARIC ACID; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; URINARY EXCRETION;

EID: 0029893386     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.7.478     Document Type: Article

References (17)

1. Park B K, Breckenridge A M. Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmaco-kinet 1981; 6: 1-24.
2. Kupfer A, Preisig R. Inherited defects of hepatic drug metabolism. Semin Liver Dis 1983; 3: 314-54.
3. Morton D M, Chatfield D H. The effects of adjuvant induced arthritis on the liver metabolism of drugs in rats. Biochem Pharmacol 1970; 19: 473-81.
4. Beck F J, Whitehouse M W. Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism. Biochem Pharmacol 1973; 22: 2453-68.
5. Cawthorne M A, Palmer E D, Green J. Adjuvant-induced arthritis and drug metabolizing enzymes. Biochem Pharmacol 1976; 25: 2683-8.
6. McKenna F, Coombes G, Sandle L, Mather H. D-Glucaric acid in rheumatoid arthritis [abstract]. Br J Rheumatol 1992; 31 (suppl 2): 115.
7. Aarts E M. Evidence for the function of D-glucarcid acid as an indicator for drug induced enhanced metabolism through the glucuronic acid pathway in man. Biochem Pharmacol 1965; 14: 359-63.
8. Sotaumi E A, Medzihradsky F, Eliasson G. Glucaric acid as an indicator of use of enzyme-inducing drugs. Clin Pharmacol Ther 1974; 15: 417-23.
9. Mowat A P. Developmental effects of liver D-glucuronolactone dehydrogenase levels on D-glucaric acid excretion in urine; hormal effects on D-glucaric acid excretion in urine. J Endocrinol 1968; 42: 585-90.
10. Marsh C A, Carr J. Changes in enzyme activity related to D-glucaric acid synthesis with age, pregnancy and malignancy. Clin Sci 1965; 28: 209-17.
11. Hunter J, Maxwell J D, Stewart D A, Williams R. Urinary D-glucaric acid excretion and total liver content of cytochrome P450 in guinea pigs: relationship during enzyme induction and following inhibition of protein synthesis. Biochem Pharmacol 1973; 22: 743-7.
12. Lecamwasam D S, Franklin C, Turner P. Effect of phenobarbitone on hepatic drug-metabolising enzymes and urinary D-glucaric acid excretion in man. Br J Clin Pharmacol 1975; 2: 257-62.
13. Gilbert J C, Scott A K, Galloway D B, Petric J C. Ethosyximide: liver enzyme induction and D-glucaric acid excretion. Br J Clin Pharmacol 1974; 1: 249-52.
14. Hunter J, Maxwell J D, Carrella M, Stewart D A, Williams R. D-glucaric acid excretion as a test for hepatic enzyme induction in man. Lancet 1971; i: 572-5.
15. Arnett F C, Edworthy S M, Bloch D, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
16. van der Linden S, Valkenburg H A, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
17. Simmons C J, Davis M, Dordoni B, Williams R. Urinary D-glucaric acid assay by an improved enzymatic procedure. Clin Chim Acta 1974; 51: 47-51.